121 related articles for article (PubMed ID: 9536454)
1. Reversal of haloperidol-induced extrapyramidal side effects in cebus monkeys by 8-hydroxy-2-(di-n-propylamino)tetralin and its enantiomers.
Christoffersen CL; Meltzer LT
Neuropsychopharmacology; 1998 May; 18(5):399-402. PubMed ID: 9536454
[TBL] [Abstract][Full Text] [Related]
2. Serotonin(1A) receptor agonism in the expression of behavioral dopaminergic supersensitivity in subchronic haloperidol treated rats.
Batool F; Haleem DJ
Pak J Pharm Sci; 2008 Oct; 21(4):411-20. PubMed ID: 18930864
[TBL] [Abstract][Full Text] [Related]
3. 5-HT1A agonist alleviates serotonergic potentiation of extrapyramidal disorders via postsynaptic mechanisms.
Shimizu S; Mizuguchi Y; Tatara A; Kizu T; Andatsu S; Sobue A; Fujiwara M; Morimoto T; Ohno Y
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():86-91. PubMed ID: 23838274
[TBL] [Abstract][Full Text] [Related]
4. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
Tada M; Shirakawa K; Matsuoka N; Mutoh S
Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of serotonin-1A receptor dependent responses following withdrawal of haloperidol in rats.
Haleem DJ; Khan NH
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Jun; 27(4):645-51. PubMed ID: 12787852
[TBL] [Abstract][Full Text] [Related]
6. Repeated treatment with 8-OH-DPAT induces tolerance to its ability to produce the 5-HT1A behavioural syndrome, but not to its ability to attenuate haloperidol-induced catalepsy.
Prinssen EP; Koek W; Colpaert FC; Kleven MS
Behav Pharmacol; 2000 Jun; 11(3-4):299-305. PubMed ID: 11103884
[TBL] [Abstract][Full Text] [Related]
7. Quinpirole, 8-OH-DPAT and ketanserin modulate catalepsy induced by high doses of atypical antipsychotics.
Ninan I; Kulkarni SK
Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):603-8. PubMed ID: 10669905
[TBL] [Abstract][Full Text] [Related]
8. Role of cortical and striatal 5-HT1A receptors in alleviating antipsychotic-induced extrapyramidal disorders.
Shimizu S; Tatara A; Imaki J; Ohno Y
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):877-81. PubMed ID: 20398719
[TBL] [Abstract][Full Text] [Related]
9. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol.
Andersen HL; Kilpatrick IC
Br J Pharmacol; 1996 May; 118(2):421-7. PubMed ID: 8735647
[TBL] [Abstract][Full Text] [Related]
10. [Effects of serotonergic drugs on the up-regulation of dopamine D2 receptors induced by haloperidol in rat striatum].
Ishikane T
Hokkaido Igaku Zasshi; 1998 Sep; 73(5):441-9. PubMed ID: 9846274
[TBL] [Abstract][Full Text] [Related]
11. Acute extrapyramidal syndrome in Cebus monkeys: development mediated by dopamine D2 but not D1 receptors.
Coffin VL; Latranyi MB; Chipkin RE
J Pharmacol Exp Ther; 1989 Jun; 249(3):769-74. PubMed ID: 2567351
[TBL] [Abstract][Full Text] [Related]
12. Estrogen treatment blocks 8-hydroxy-2-dipropylaminotetralin- and apomorphine-induced disruptions of prepulse inhibition: involvement of dopamine D1 or D2 or serotonin 5-HT1A, 5-HT2A, or 5-HT7 receptors.
Gogos A; Kwek P; Chavez C; van den Buuse M
J Pharmacol Exp Ther; 2010 Apr; 333(1):218-27. PubMed ID: 20042529
[TBL] [Abstract][Full Text] [Related]
13. Role of serotonin-1A receptors in the action of antipsychotic drugs: comparison of prepulse inhibition studies in mice and rats and relevance for human pharmacology.
Gogos A; Bogeski M; van den Buuse M
Behav Pharmacol; 2008 Sep; 19(5-6):548-61. PubMed ID: 18690109
[TBL] [Abstract][Full Text] [Related]
14. Contrasting contribution of 5-hydroxytryptamine 1A receptor activation to neurochemical profile of novel antipsychotics: frontocortical dopamine and hippocampal serotonin release in rat brain.
Assié MB; Ravailhe V; Faucillon V; Newman-Tancredi A
J Pharmacol Exp Ther; 2005 Oct; 315(1):265-72. PubMed ID: 15987834
[TBL] [Abstract][Full Text] [Related]
15. Interaction between anti-Alzheimer and antipsychotic drugs in modulating extrapyramidal motor disorders in mice.
Shimizu S; Mizuguchi Y; Sobue A; Fujiwara M; Morimoto T; Ohno Y
J Pharmacol Sci; 2015 Apr; 127(4):439-45. PubMed ID: 25850380
[TBL] [Abstract][Full Text] [Related]
16. Contribution of the serotonin 5-HT1A receptor agonism of 8-OH-DPAT and EMD 128130 to the regulation of haloperidol-induced muscle rigidity in rats.
Lorenc-Koci E; Wardas J; Bartoszyk GD; Wolfarth S
Neuropharmacology; 2003 Dec; 45(8):1057-69. PubMed ID: 14614949
[TBL] [Abstract][Full Text] [Related]
17. 8-OH DPAT can restore the locomotor stimulant effects of cocaine blocked by haloperidol.
Carey R; Damianopoulos E; De Palma G
Pharmacol Biochem Behav; 2000 Aug; 66(4):863-72. PubMed ID: 10973527
[TBL] [Abstract][Full Text] [Related]
18. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ
J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172
[TBL] [Abstract][Full Text] [Related]
19. The adenosine A2A receptor agonist CGS 21680 exhibits antipsychotic-like activity in Cebus apella monkeys.
Andersen MB; Fuxe K; Werge T; Gerlach J
Behav Pharmacol; 2002 Dec; 13(8):639-44. PubMed ID: 12478214
[TBL] [Abstract][Full Text] [Related]
20. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
Bruins Slot LA; Lestienne F; Grevoz-Barret C; Newman-Tancredi A; Cussac D
Eur J Pharmacol; 2009 Oct; 620(1-3):27-35. PubMed ID: 19695244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
